Haefeli WE - Search Results

1

Drug dosage in patients with renal failure optimized by immediate concurrent feedback.

Falconnier AD, Haefeli WE, Schoenenberger RA, Surber C, Martin-Facklam M. Falconnier AD, et al. Among authors: haefeli we. J Gen Intern Med. 2001 Jun;16(6):369-75. doi: 10.1046/j.1525-1497.2001.016006369.x. J Gen Intern Med. 2001. PMID: 11422633 Free PMC article.

2

Possible risk for cardiac arrhythmia related to intravenous erythromycin.

Haefeli WE, Schoenenberger RA, Weiss P, Ritz R. Haefeli WE, et al. Intensive Care Med. 1992;18(8):469-73. doi: 10.1007/BF01708583. Intensive Care Med. 1992. PMID: 1289371 Review.

3

Recurrent ventricular fibrillation in mianserin intoxication.

Haefeli WE, Schoenenberger RA, Scholer A. Haefeli WE, et al. BMJ. 1991 Feb 16;302(6773):415-6. doi: 10.1136/bmj.302.6773.415-d. BMJ. 1991. PMID: 2004160 Free PMC article. No abstract available.

4

Timing of invasive procedures in therapy for primary and secondary spontaneous pneumothorax.

Schoenenberger RA, Haefeli WE, Weiss P, Ritz RF. Schoenenberger RA, et al. Among authors: haefeli we. Arch Surg. 1991 Jun;126(6):764-6. doi: 10.1001/archsurg.1991.01410300110017. Arch Surg. 1991. PMID: 2039365

5

Association of intravenous erythromycin and potentially fatal ventricular tachycardia with Q-T prolongation (torsades de pointes).

Schoenenberger RA, Haefeli WE, Weiss P, Ritz RF. Schoenenberger RA, et al. Among authors: haefeli we. BMJ. 1990 May 26;300(6736):1375-6. doi: 10.1136/bmj.300.6736.1375. BMJ. 1990. PMID: 2372583 Free PMC article. No abstract available.

6

Evaluation of conventional chest tube therapy for iatrogenic pneumothorax.

Schoenenberger RA, Haefeli WE, Weiss P, Ritz R. Schoenenberger RA, et al. Among authors: haefeli we. Chest. 1993 Dec;104(6):1770-2. doi: 10.1378/chest.104.6.1770. Chest. 1993. PMID: 8252961

7

Acyclovir-induced neurotoxicity: concentration-side effect relationship in acyclovir overdose.

Haefeli WE, Schoenenberger RA, Weiss P, Ritz RF. Haefeli WE, et al. Am J Med. 1993 Feb;94(2):212-5. doi: 10.1016/0002-9343(93)90186-s. Am J Med. 1993. PMID: 8430717 Review.

8

Haunting medicines.

Schuerch LV, Nyfeler J, Holder G, Surber C, Haefeli WE. Schuerch LV, et al. Among authors: haefeli we. Am J Health Syst Pharm. 1997 Oct 15;54(20):2403. doi: 10.1093/ajhp/54.20.2403. Am J Health Syst Pharm. 1997. PMID: 9347104 No abstract available.

9

[Tablets in stool? A common problem!].

Schuerch LV, Nyfeler J, Holder G, Surber C, Haefeli WE. Schuerch LV, et al. Among authors: haefeli we. Schweiz Med Wochenschr. 1999 May 1;129(17):670-3. Schweiz Med Wochenschr. 1999. PMID: 10407938 German.

10

Academic detailing improves identification and reporting of adverse drug events.

Schlienger RG, Lüscher TF, Schoenenberger RA, Haefeli WE. Schlienger RG, et al. Among authors: haefeli we. Pharm World Sci. 1999 Jun;21(3):110-5. doi: 10.1023/a:1008631926100. Pharm World Sci. 1999. PMID: 10427579 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

588 results

Search Page

Filters